Known targets — ChEMBL curated mechanism
The experimentally established mechanism targets of Allopurinol. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | XDH known ✓ | P47989 | 1/20 | 0.57 |
| ▸ | RET | P07949 | 1/20 | 0.57 |
| ▸ | PI4KA | P42356 | 1/20 | 0.57 |
| ▸ | LRRK2 | Q5S007 | 1/20 | 0.57 |
| ▸ | PI4K2B | Q8TCG2 | 1/20 | 0.57 |
| ▸ | PI4K2A | Q9BTU6 | 1/20 | 0.57 |
| ▸ | PI4KB | Q9UBF8 | 1/20 | 0.57 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.39 |
| ▸ | PDPK1 | O15530 | 2/20 | 0.39 |
| ▸ | CHEK1 | O14757 | 1/20 | 0.38 |
| ▸ | AURKA | O14965 | 1/20 | 0.38 |
| ▸ | TTBK1 | Q5TCY1 | 1/20 | 0.36 |
| ▸ | LMNA | P02545 | 1/20 | 0.35 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.35 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.35 |
| ▸ | HPGDS | O60760 | 1/20 | 0.35 |
| ▸ | AKT2 | P31751 | 2/20 | 0.34 |
| ▸ | CCNA2 | P20248 | 2/20 | 0.34 |
| ▸ | CDK2 | P24941 | 2/20 | 0.34 |
| ▸ | CCNA1 | P78396 | 2/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Allopurinol SCHEMBL29693720 | 0.80 | XDH (0.61) | RETPI4KAXDHLRRK2PI4K2B | |
| Allopurinol SCHEMBL4627 | 0.80 | XDH (0.61) | RETPI4KAXDHLRRK2PI4K2B | |
| SCHEMBL11362 | 0.80 | PI4KA (0.45) | RETPI4KAXDHLRRK2PI4K2B | |
| Allopurinol SCHEMBL4708652 | 0.80 | XDH (0.61) | RETPI4KAXDHLRRK2PI4K2B | |
| Allopurinol SCHEMBL21362860 | 0.78 | XDH (0.59) | RETPI4KAXDHLRRK2PI4K2B | |
| Allopurinol SCHEMBL137084 | 0.78 | XDH (0.59) | RETPI4KAXDHLRRK2PI4K2B | |
| Allopurinol SCHEMBL7202468 | 0.78 | XDH (0.59) | RETPI4KAXDHLRRK2PI4K2B | |
| Hydrochloric Acid SCHEMBL1741651 | 0.78 | PI4KA (0.44) | RETPI4KAXDHLRRK2PI4K2B | |
| Hydrochloric Acid SCHEMBL14742344 | 0.78 | PI4KA (0.44) | RETPI4KAXDHLRRK2PI4K2B | |
| Allopurinol SCHEMBL27973688 | 0.78 | XDH (0.59) | RETPI4KAXDHLRRK2PI4K2B |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20080089957-A1 | Monocotyledon plant indications extract compositions, method of preparation and pharmaceutical compositions containing them | ACADEMIA SINICA (TW) | 2008-04-17 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080089957-A1 | Monocotyledon plant indications extract compositions, method of preparation and pharmaceutical compositions containing them | OAT, TPMT, NUDT1 | XDH 5/4885RET 3750/4885PI4KA 4187/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.